Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Regenerative Medicine Market: By Product Type, By Technology, By Application, By End-user and Geography
Regenerative Medicine Market size was valued at US$ 9.8 billion in 2023 and is poised to grow at a CAGR of 15.2% from 2024-2030. Regenerative medicines are those, that replace, repair, and regenerate organ and tissues affected due to disease, injury, and the natural aging process. Regenerative medicines have a wide range of applications and are used in neurodegenerative, cardiovascular, orthopedic, and dermatological disorders. Regenerative medicines also include the possibility of growing organs and tissues in the laboratory and implanting them when the body cannot heal itself.
The major biomedical approaches in regenerative medicine are stem cells which have the ability of differentiation and proliferation of cells. An increase in the prevalence of genetic disorders, a rise in funding from public and private sectors for R&D activities in regenerative medicines, an increase in healthcare expenditure, and various products in the pipeline are expected to fuel the regenerative medicines market over the forecast period. Furthermore, technological advancements in stem cell therapy and nanotechnology, the growing need for orthopedic surgeries, and an increase in awareness about regenerative medicines among key stakeholders might propel the market growth over the forecast period.
Study Period
2024-2030Base Year
2023CAGR
15.2%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Regenerative medicine market is growing at a significant CAGR owing to increase in the prevalence of chronic diseases such as cancer, cardiovascular, and neurological disorders. Increase in the number of organ transplantation and surgical procedures is expected to drive the market growth over the forecast period. Acquisitions, mergers, and collaborations between the companies, and introduction technologically advanced products might increase the competitor’s revenue share in the regenerative medicines market. For instance, in December 2016, Allergan has acquired Lifecell for expanding its product portfolio in a hernia and breast reduction surgeries. Similarly, in June 2014, Aastrom Biosciences acquired the Sanofi's cell therapy and regenerative business segment for strengthening its cell therapy portfolio. Moreover, in March 2016, Hitachi Chemical and Caladrius Biosciences PCT inked an agreement for the manufacturing of regenerative medicine cells.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 9.8 billion |
Market CAGR |
15.2% |
By Product Type |
|
By Technology |
|
By Application |
|
By End User |
|
Download Free Sample Report
The global regenerative medicine market size was valued at US$ 9.8 billion in 2023 and is projected to grow at a CAGR of 15.2% from 2024-2030.
The regenerative medicine market key players are Osiris Therapeutics, Inc. (U.S.) Organogenesis Inc. (U.S.) NuVasive, Inc. (U.S.) Acelity (KCI Concepts) (U.S.) Stryker Corporation (U.S.) Integra LifeSciences (U.S.) Hitachi, Ltd. (Japan) Vericel Corporation (U.S.)
The regenerative medicine possibility of growing organs and tissues in the laboratory and implanting them when the body cannot heal itself.
1.Executive Summary |
2.Global Regenerative Medicine Market Introduction |
2.1.Global Regenerative Medicine Market - Taxonomy |
2.2.Global Regenerative Medicine Market - Definitions |
2.2.1.Product Type |
2.2.2.Application |
2.2.3.Application |
2.2.4.End User |
2.2.5.Region |
3.Global Regenerative Medicine Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Regenerative Medicine Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Regenerative Medicine Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Biologically Derived Materials |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Genetically Engineered Materials |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Synthetic Materials |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Pharmaceuticals |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6.Global Regenerative Medicine Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Gene Therapy |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Small Molecules And Biologicals |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Cell Therapy |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Tissue Engineering |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Regenerative Medicine Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Dermatology |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Cardiovascular |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Orthopaedic |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Oncology |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Wound healing |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Neurology |
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
7.7. Ophthalmology |
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.7.3. Market Opportunity Analysis |
7.8. Others |
7.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.8.3. Market Opportunity Analysis |
8.Global Regenerative Medicine Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Hospitals |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Clinics |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Research Laboratories |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Others |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9.Global Regenerative Medicine Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Regenerative Medicine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Biologically Derived Materials |
10.1.2.Genetically Engineered Materials |
10.1.3.Synthetic Materials |
10.1.4.Pharmaceuticals |
10.1.5.Others |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Gene Therapy |
10.2.2.Small Molecules And Biologicals |
10.2.3.Cell Therapy |
10.2.4.Tissue Engineering |
10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Dermatology |
10.3.2.Cardiovascular |
10.3.3.Orthopaedic |
10.3.4.Oncology |
10.3.5.Wound healing |
10.3.6.Neurology |
10.3.7.Ophthalmology |
10.3.8.Others |
10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals |
10.4.2.Clinics |
10.4.3.Research Laboratories |
10.4.4.Others |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Regenerative Medicine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Biologically Derived Materials |
11.1.2.Genetically Engineered Materials |
11.1.3.Synthetic Materials |
11.1.4.Pharmaceuticals |
11.1.5.Others |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Gene Therapy |
11.2.2.Small Molecules And Biologicals |
11.2.3.Cell Therapy |
11.2.4.Tissue Engineering |
11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Dermatology |
11.3.2.Cardiovascular |
11.3.3.Orthopaedic |
11.3.4.Oncology |
11.3.5.Wound healing |
11.3.6.Neurology |
11.3.7.Ophthalmology |
11.3.8.Others |
11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals |
11.4.2.Clinics |
11.4.3.Research Laboratories |
11.4.4.Others |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
12.Asia Pacific (APAC) Regenerative Medicine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Biologically Derived Materials |
12.1.2.Genetically Engineered Materials |
12.1.3.Synthetic Materials |
12.1.4.Pharmaceuticals |
12.1.5.Others |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Gene Therapy |
12.2.2.Small Molecules And Biologicals |
12.2.3.Cell Therapy |
12.2.4.Tissue Engineering |
12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Dermatology |
12.3.2.Cardiovascular |
12.3.3.Orthopaedic |
12.3.4.Oncology |
12.3.5.Wound healing |
12.3.6.Neurology |
12.3.7.Ophthalmology |
12.3.8.Others |
12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals |
12.4.2.Clinics |
12.4.3.Research Laboratories |
12.4.4.Others |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Regenerative Medicine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Biologically Derived Materials |
13.1.2.Genetically Engineered Materials |
13.1.3.Synthetic Materials |
13.1.4.Pharmaceuticals |
13.1.5.Others |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Gene Therapy |
13.2.2.Small Molecules And Biologicals |
13.2.3.Cell Therapy |
13.2.4.Tissue Engineering |
13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Dermatology |
13.3.2.Cardiovascular |
13.3.3.Orthopaedic |
13.3.4.Oncology |
13.3.5.Wound healing |
13.3.6.Neurology |
13.3.7.Ophthalmology |
13.3.8.Others |
13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals |
13.4.2.Clinics |
13.4.3.Research Laboratories |
13.4.4.Others |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Regenerative Medicine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Biologically Derived Materials |
14.1.2.Genetically Engineered Materials |
14.1.3.Synthetic Materials |
14.1.4.Pharmaceuticals |
14.1.5.Others |
14.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Gene Therapy |
14.2.2.Small Molecules And Biologicals |
14.2.3.Cell Therapy |
14.2.4.Tissue Engineering |
14.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Dermatology |
14.3.2.Cardiovascular |
14.3.3.Orthopaedic |
14.3.4.Oncology |
14.3.5.Wound healing |
14.3.6.Neurology |
14.3.7.Ophthalmology |
14.3.8.Others |
14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals |
14.4.2.Clinics |
14.4.3.Research Laboratories |
14.4.4.Others |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Osiris Therapeutics, Inc. (U.S.) |
15.2.2.Organogenesis Inc. (U.S.) |
15.2.3.NuVasive, Inc. (U.S.) |
15.2.4.Acelity (KCI Concepts) (U.S.) |
15.2.5.Stryker Corporation (U.S.) |
15.2.6.Integra LifeSciences (U.S.) |
15.2.7.Hitachi, Ltd. (Japan) |
15.2.8.Vericel Corporation (U.S.) |
15.2.9.C.R. Bard (U.S.) |
15.2.10.Allergan (Ireland) |
15.2.11.Caladrius Biosciences (U.S.) |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players